acetylcysteine has been researched along with Anterior Choroidal Artery Infarction in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aw, TY; Stokes, KY; Wang, B | 1 |
Carroll, JE; Chen, Q; Cheng, C; Hess, DC; Howard, EF; Wakade, CG | 1 |
Adams, J; Chopp, M; Elliott, PJ; Lu, M; Zhang, L; Zhang, RL; Zhang, ZG | 1 |
3 other study(ies) available for acetylcysteine and Anterior Choroidal Artery Infarction
Article | Year |
---|---|
The protection conferred against ischemia-reperfusion injury in the diabetic brain by N-acetylcysteine is associated with decreased dicarbonyl stress.
Topics: Acetylcysteine; Animals; Antioxidants; Blood-Brain Barrier; Brain; Cerebral Infarction; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucose; Glutamate-Cysteine Ligase; Glutathione; Humans; Mice; Oxidative Stress; Pyruvaldehyde; Reperfusion Injury; Stroke | 2016 |
Nuclear factor-kappa B activation during cerebral reperfusion: effect of attenuation with N-acetylcysteine treatment.
Topics: Acetylcysteine; Animals; Antioxidants; Cerebral Arteries; Cerebral Infarction; Injections, Intraperitoneal; Ischemic Attack, Transient; Male; NF-kappa B; Rats; Rats, Wistar; Reperfusion Injury | 1998 |
Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia.
Topics: Acetylcysteine; Animals; Behavior, Animal; Blood Pressure; Body Weight; Brain Ischemia; Cell Count; Cerebral Hemorrhage; Cerebral Infarction; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Intracranial Embolism; Male; Multienzyme Complexes; Neurologic Examination; Peroxidase; Proteasome Endopeptidase Complex; Rats; Rats, Wistar; Recombinant Proteins; Time Factors; Tissue Plasminogen Activator | 2001 |